article thumbnail

Will enterprises soon keep their best gen AI use cases under wraps?

CIO

Normally, a CCO develops ideas about what the market needs and communicates them to a design team, which produces sketches to then be reviewed by the CCO. As the technology exhausts its honeymoon period, and companies in all industries find new ways of using it to get ahead of the competition, a new race is on.

Biotech 726
article thumbnail

Harnham Seeks Senior Competitive Intelligence Manager for Biotech Company

ArchIntel

Recruitment company Harnham has posted a job advertisement for a senior manager of competitive intelligence who will be based in Boston, Massachusetts. The role will provide competitive intelligence and strategic insights across organizations within a company that focuses on biotechnology. ArchIntel™ -.

Biotech 104
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

US Telecommunications Industry to Maintain Growth Amid Competition-Charged Environment

ArchIntel

Studies indicate that during the five-year period between 2016 to 2021, the size of the industry has been steady, owing to the almost complete market penetration locally. The grip telcos have over their market is demonstrated by the 134.46 Executive Profile: Zack Fields, Senior Manager of Mover Marketing at Cox Communications.

article thumbnail

PharmaEssentia Looking for BI and Analytics Director

ArchIntel

“The global pharmaceuticals market size is expected to gain momentum by reaching USD 2,151.1 This includes delivering actionable market, customer and product insights to help the company achieve its commercial goals. The role also has competitive intelligence functions. ArchIntel™ -. between 2020 and 2027.”

Biotech 104
article thumbnail

Slow Start to Venture Capital Funding in 2024

Alpha Sense BI

Below, we explore the factors constraining venture capital funding into the first half of the year, and the ways investors can leverage crucial market intelligence to gain a competitive advantage in the shifting landscape. The VC Funding Dryspell Venture capital investment fell to the lowest activity in nearly five years for Q1 2024.

Capital 69
article thumbnail

Key Takeaways from J.P. Morgan’s 41st Annual Healthcare Conference?

Alpha Sense BI

Specifically, within the pharma and biotech sectors, there have been 22 deals announced so far in 2023 — again, a low number compared to the 70 made over the same period last year. Additionally, unprofitable biopharma, aka most biotech companies, is expected to invest $1.1

Biotech 96
article thumbnail

Global Healthcare Industry – M&A and Capital Market Landscape Update

Evalueserve

Global Healthcare Market – 2021. Mass vaccination drives in advanced economies are instilling positive market sentiments with the presumption of stability. The ability to identify, negotiate and realize value from increasingly complex partnerships and alternative collaboration models has become an important competitive advantage.

Capital 98